AllianceBernstein
AMPE

AllianceBernstein’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

AllianceBernstein’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-65
Closed -$9K – 3452
2022
Q1 		$9K Hold
65
– – ﹤0.01% 3239
2021
Q4 		$11K Hold
65
– – ﹤0.01% 3289
2021
Q3 		$32K Hold
65
– – ﹤0.01% 3241
2021
Q2 		$32K Buy
+65
New +$34.9K ﹤0.01% 3294
2018
Q4 		– Sell
-35
Closed -$5K – 3161
2018
Q3 		$5K Hold
35
– – ﹤0.01% 3138
2018
Q2 		$23K Buy
+35
New +$26.2K ﹤0.01% 3105
2015
Q2 		– Sell
-109
Closed -$246K – 3340
2015
Q1 		$246K Hold
109
– – ﹤0.01% 2748
2014
Q4 		$112K Hold
109
– – ﹤0.01% 2970
2014
Q3 		$115K Sell
109
-26
-19% -$43.8K ﹤0.01% 2933
2014
Q2 		$338K Buy
135
+16
+13% +$32.7K ﹤0.01% 2633
2014
Q1 		$226K Buy
119
+1
+0.8% +$2.37K ﹤0.01% 2721
2013
Q4 		$252K Sell
118
-26
-18% -$61.5K ﹤0.01% 2730
2013
Q3 		$324K Buy
144
+3
+2% +$5.8K ﹤0.01% 2690
2013
Q2 		$245K Buy
+141
New +$224K ﹤0.01% 2784

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein's AMPE Position: Q2 2022 in Review

AllianceBernstein sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 65 shares — an estimated $9K sold.

AllianceBernstein first reported a position in AMPE in Q2 2013 and held it in 14 quarters. The position peaked at $338K in Q2 2014. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.

  • AllianceBernstein reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
  • AllianceBernstein sold 65 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $9K.
  • AllianceBernstein first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 14 quarters.
  • AllianceBernstein's Ampio Pharmaceuticals Inc. position peaked at $338K in Q2 2014.
  • 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.

Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.